Provisional programme topics to cover
- Point of care cardiac marker testing.
- New models of delivery of cardiac care using biomarker measurement in the community for both acute and chronic care to include the concept of acute care units and a more decentralized model of care.
- State-of-the-art review of cardiac troponin testing to include the new cardiac troponin T assay as well as fragment assays.
- The universal definition of myocardial infarction.
- Other cardiac biomarkers past present and future. The objective is to give a state-of-the-art review as to the what has been proposed and what happened to them and what novel markers are on the horizon.
- Biomarkers of risk to include the role of high sensitivity cardiac troponin and Lipoprotein(a) including a discussion of methodology problems.
- Clinical trial design for cardiac biomarkers covering what has been performed so far and what we really should be doing.
- Are we training young laboratory scientists and clinical medical staff on how to become involved in clinical trials. Plus key tips for obtaining funding.